Cohort Study: In Patients with Acute Coronary Syndrome Who Underwent PCI, Use of Ticagrelor was Not Associated with Reduced Coronary Events and Was Associated with More Major Bleeding and Dyspnea When Compared to Clopidogrel

14 Jan, 2020 | 00:32h | UTC

Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention – JAMA Internal Medicine (free for a limited period)

Commentary: Brilinta Questioned for Acute Coronary Syndrome – MedPage Today (free registration required)

 

Join our WhatsApp group

Free Updates in All Specialties!

A daily update on the latest medical news, practice-changing trials and guidelines

Stay Updated in Your Specialty
No spam, just news
Unsubscribe with one click

 

Daily

 

Weekly or Less Often 
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •